Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0000950170-25-012043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-03 | 2025-01-30 | HRTX | Morgan Adam | Dir | A - Grant | $0.00 | +17.9K | 69.8K | +35% | $0 |
| D | 2025-02-03 | 2025-01-30 | HRTX | Morgan Adam | Dir | A - Grant | $1.73 | +35.9K | 35.9K | New | +$62.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-30 | A | A | 17,950 | $0.00 | 69,777 | D | — | — | (F1) The shares were granted as restricted stock units which vest in full on January 30, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-30 | A | A | 35,900 | $1.73 | 35,900 | D | $1.73 · — to 2035-01-30 | 35,900 Common Stock | (F3) The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |